COMMUNIQUÉS West-GlobeNewswire

scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX®

13/06/2018 - 14:00

BURLINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]

Atara Biotherapeutics Announces Publication of New Research Linking Epstein-Barr Virus (EBV) Infection and Multiple Sclerosis (MS)

13/06/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]

Immunomedics Announces Pricing of Public Offering of Common Stock

13/06/2018 - 14:00

MORRIS PLAINS, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Tetra Bio-Pharma Inc. Provides Corporate Update Ahead of Its Annual General Meeting

13/06/2018 - 14:00

ORLEANS, Ontario, June 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (“ Tetra ” or the “ Corporation ”) (TSX VENTURE:TBP) (OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is [...]

Corium Announces Issuance of Key U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease

13/06/2018 - 13:30

Provides Composition of Matter Coverage to 2037 MENLO PARK, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, [...]

Metacrine Completes Dosing of First Cohort in Phase 1 Trial of MET409, a Novel Non-Bile Acid FXR Agonist

13/06/2018 - 13:30

SAN DIEGO, June 13, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced dosing of [...]

Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference

13/06/2018 - 13:30

Research includes clinical trial data across broad SMA patient populations, expanding scientific understanding of SMA and SPINRAZA® (nusinersen) Study presented examines neurofilament (pNF-H) as a potential biomarker [...]

Assembly Biosciences to Host Research and Development Day on Wednesday, June 20, 2018

13/06/2018 - 13:05

Live event and webcast to focus on the potential of curative therapy for HBV infection and feature presentations from two liver medicine specialists INDIANAPOLIS and SAN FRANCISCO, June 13, 2018 (GLOBE NEWSWIRE) -- [...]

Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy

13/06/2018 - 13:01

FDA Approved, DBS Clinician Programmer Optimizes the Programming Experience By Addressing Day-to-Day Clinical Management Challenges DUBLIN - June 13, 2018 - Medtronic plc ( NYSE:MDT), the global leader in medical [...]

Revive Therapeutics and WeedMD Sign Medical Cannabis R&D Supply and Collaboration Agreements

13/06/2018 - 13:00

TORONTO, June 13, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX-V:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive”) , a company focused on the research, development and commercialization of novel cannabinoid-based [...]

Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting

13/06/2018 - 13:00

Results showed that oat avenanthramides supplementation reduce circulatory inflammation and inhibit expressions of chemokines and adhesion molecules EDMONTON, Alberta, June 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX- [...]

Akcea Announces Completion of Landmark Study to Assess Disease Burden in People Living with FCS

13/06/2018 - 13:00

Results published in Expert Review of Cardiovascular Therapy CAMBRIDGE, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing [...]

Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference

13/06/2018 - 13:00

CAMBRIDGE, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph. [...]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

13/06/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., June 13, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ:BCRX), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:IDRA), today announced that [...]

PetVivo Holdings, Inc. Adds Dr. Tracy Turner, Creates Veterinary Advisory Board

13/06/2018 - 13:00

MINNEAPOLIS, June 13, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKET:PETV), an emerging biomedical device company, is pleased to announce the addition of Dr. Tracy Turner of The Turner [...]

Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018

13/06/2018 - 13:00

LEXINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today late [...]

Avivagen Announces Distribution Agreement in Thailand

13/06/2018 - 12:30

OTTAWA, Ontario, June 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion [...]

Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft

13/06/2018 - 12:00

Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT ® Approved in U.S. for Ankle and/or Hindfoot Fusion Company Can Now Initiate Commercial Sale and Distribution in the U.S. Company Plans to Update 2018 [...]

Japanese Medical Agency (PMDA) supports the expansion of the Phase III program for PledOx® to include Japanese patients

13/06/2018 - 08:30

Stockholm, June 13, 2018. PledPharma AB and Solasia Pharma K.K. (Solasia) today announced that the Japanese Pharmaceuticals and Medical Devices Agency, PMDA, following a meeting with PledPharma and Solasia, has [...]